Stealth BioTherapeutics (Stealth BioTherapeutics) Accounts Receivable : $0.00 Mil (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Stealth BioTherapeutics's accounts receivables for the quarter that ended in Mar. 2022 was $0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Stealth BioTherapeutics's Net-Net Working Capital per share for the quarter that ended in Mar. 2022 was $-0.92.

Stealth BioTherapeutics Accounts Receivable Historical Data

The historical data trend for Stealth BioTherapeutics's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Accounts Receivable Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Accounts Receivable

Get a 7-Day Free Trial

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Accounts Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Stealth BioTherapeutics Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Stealth BioTherapeutics Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Stealth BioTherapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Stealth BioTherapeutics's accounts receivable are only considered to be worth 75% of book value:

Stealth BioTherapeutics's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(33.834	+	0.75 * 0	+	0.5 * 0	-	89.232
-	0	-	0)	/	59.9706
=	-0.92

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Stealth BioTherapeutics Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.